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Abstract
Background: Type 2 diabetes mellitus has been identified as one of the priority diseases and included in the
essential public health service package in China. This study investigated the frequency of follow-up visits and
contents of care for case management of patients with Type 2 diabetes in Chongqing located in the western
China, in terms of the regional practice guideline; and analyzed factors associated with the use of care.
Methods: A cross-sectional survey was conducted with patients diagnosed with Type 2 diabetes in two areas in
Chongqing. Total 502 participants (out of 664 people eligible) completed the interview. The outcome measures
included at least four follow-up visits in a year, annual HbA1c test, blood lipid test and diabetic screening for
nephropathy and eyes. Logistic regression analysis was applied to examine the association between participants’
demographic and socio-economic characteristics and outcome measures.
Results: Over the one-year study period, 65% of participants had four or more follow-up visits. In light of the
recommended tests, the proportions of having HbA1c test, blood lipid test and screening for nephropathy and
eyes annually were 8, 54, 45 and 44%, respectively. After adjusting for study sites, age, sex, education, type of
residence, level of income, the patients who were covered by Urban Employee Basic Medical Insurance, were
enrolled in the targeted disease reimbursement program, and lived with diabetes more than five years were
more likely to have regular follow-up visits and the recommended tests.
Conclusions: Case management for patients with Type 2 diabetes mellitus was not effectively implemented in
terms of frequency of follow-up visits and recommended tests over one-year period, as indicated in the regional
practice guideline.
Keywords: Type 2 diabetes mellitus, Chronic disease case management, Compliance, China
Background
Diabetes mellitus (DM) is one of the top ten causes of
disability in the world and undermines productivity and
human development [1]. In China, it is estimated that
the prevalence of diabetes is 9.4% in 2016 and approxi-
mately 224,700 people die from diabetes [2]. It is there-
fore particularly important that the public health system
ensures the delivery of effective healthcare services to
those with the disease.
China’s National Plan for Non-Communicable Dis-
eases (NCDs) Prevention and Treatment (2012–2015)
adopts primary healthcare approach highlighting the im-
portance of early diagnosis and early treatment of NCDs
[3]. Type 2 DM has been identified as one of the priority
diseases in China. According to the national guideline
for implementation of the basic public health service
package, case management should be provided with
patients with Type 2 DM once a quarter aiming to
monitor the disease progression, guide the treatment
and promote healthy lifestyle [4]. The recommended
services for case management included blood glucose
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test and other relevant examinations, routine physical
check-up, health education and nutrition guidance.
In China, there are three basic health insurance
schemes covering over 95% of the population. They are
Urban Employee Basic Medical Insurance (UEBMI),
Urban Residence Basic Medical Insurance (URBMI) and
New Rural Cooperative Medical Scheme (NCMS) [5, 6].
UEBMI has relatively comprehensive coverage of health
services. URBMI and NCMS largely cover inpatient care,
and in the recent years they also provide outpatient
coverage, albeit the benefit package being modest [7].
Chongqing is one of the largest cities located in the
western China, with a total population of over 30 mil-
lion. The prevalence of diabetes in Chongqing was
10.7% in 2014 [8]. In 2010, the two schemes, URBMI
and NCMS were integrated in one scheme, named as
Urban–rural Residence Basic Medical Insurance
(URRBMI) in Chongqing. This scheme and UEBMI have
a targeted disease reimbursement program to provide a
higher level of reimbursement for outpatient care for 20
priority disease, including DM [5]. In line with the
national plan for NCDs management and treatment, the
provincial government has issued a practice guideline
targeting on management of elder people and patients
with Type 2 DM and hypertension, which has intro-
duced a set of indicators for monitoring and evalu-
ation of NCDs management [9]. Regarding the
diabetic case management, the guideline recom-
mended one face-to-face visit every quarter and a
comprehensive check-up and in a year (including rou-
tine blood and urine tests, electrocardiogram, liver
and kidney function examinations, HbA1c test and
diabetic eyes screening).
Many previous studies in China focused on the
treatment of Type 2 DM [10, 11] but few studies ex-
amined case management for Type 2 DM patients.
This study investigated the frequency of follow-up
visits and contents of care for case management of
patients with Type 2 DM in Chongqing, in terms of
regional practice guideline; and analyzed factors asso-
ciated with the use of care.
Methods
Study sites
The cross-sectional patient survey was carried out in
two areas where the NCDs management and registry
systems have been established. The two selected areas
represented, respectively, less developed area (DJ
County) and developed one (YB District) in Chongqing.
Table 1 presents the basic characteristics of the study
sites. One township and one community were selected
in each area which was near to and far from county/dis-
trict hospital, and the local health authorities would like
to participate in the study.
Participants and data collection
Eligible participants were men and women who have
been diagnosed with Type 2 DM before 2013 and were
registered in the chronic disease management system at
the health centers. Pregnant women with gestational
DM were excluded. The total number of eligible partici-
pants was 664. The survey was carried out between June
to September 2014. Trained university students and
teachers conducted the interview using a structured
questionnaire developed by the research team, which
was finalized after the pilot test. The questions included
demographic and socioeconomic characteristics of
participants, years of patients living with DM, frequency
of having follow-up visits in a year, contents of care
(referred to the local practice guideline) and expendi-
tures of health services used. Staffs working in the health
centers contacted and invited all eligible participants to
come to a place where was convenient for patients. The
interviews were conducted using local dialect in a pri-
vate room. Total 502 participants (out of 664) completed
the interview.
Data analysis
In the study, outcome measures referred to the recom-
mendations of the regional practice guideline for the
management of Type 2 DM. They were at least four
follow-up visits in a year, HbA1c test, blood lipid test,
diabetic eye and nephropathy screening once a year, re-
spectively. Participants who had less than four follow-up
visits or didn’t have any of test mentioned above were
considered as sub-standard management. Explanatory
variables included participants’ age (≤59,60-69,≥70), gen-
der (male and female), type of residence (urban, rural),
education (illiterate, primary school, middle school or
higher), level of income (low, middle and high), type of
health insurance (UEBMI or URRBMI), the enrollment
Table 1 Characteristics of study sites, 2013
Items DJ county YB district




Selected sites One township (GF):
around 25 km from
the county hospital
One township (LX):
around 16 km from
the district hospital
One community (GX):
nearest to the county
hospital
One community (SFQ):
nearest to the district
hospital




product per capita (US$)a
4612.90 11145.16
aGross domestic product per capita in Chongqing was 6903.23 US dollars
in 2013
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status of the targeted disease reimbursement program
(yes, no) and years of living with Type 2 DM (≤5, >5).
Income category was grouped, using annual per capita
income. The reported annual household income (which
represented total annual consumption and savings in a
calendar year prior to the survey) was divided by the
number of family members and grouped into three in-
come categories (DJ County and YB District respect-
ively), each containing a third of patients. The targeted
disease reimbursement program in health insurance
schemes provided a higher level of reimbursement for
DM outpatient and/or inpatient care for those who were
diagnosed with DM and requested to enroll in this pro-
gram. The more details of the targeted disease reim-
bursement program were reported elsewhere [5].
The completed questionnaires were cross-checked,
and any logical mistakes were corrected. The data were
double-entered into the database (EpiData version 3.1).
Cross tabulation was used to compare follow-up man-
agement of DM in the two study sites. The multi-
collinearity diagnosis was performed showing no evi-
dence of multi-collinearity among variables. The multi-
variable logistical regression (stepwise selection) was
used to examine the associations between all explanatory
variables and outcome measures. Data without statisti-
cally significant were not shown. Odds Ratios (OR) and
their 95% confidence intervals (95% CI) were calculated.
The SAS 9.1.3 was used for statistical analyses.
This study was approved by the Research Ethics
Committee of Chongqing Medical University. Written
consents of participants were obtained for data
collection.
Results
Demographic and socioeconomic characteristics
Of 502 participants, six participants did not complete
the section of content of care for the case management
in the questionnaire. Thus, total 496 participants were
included in this analysis. Table 2 presents the character-
istics of participants. In the both study sites, a vast ma-
jority of participants were over 60 years old and there
were more women than men. All participants had health
insurance coverage: three-fourth of them covered by the
URRBMI, while less than one-third of all participants
were enrolled in the targeted disease reimbursement
program. Around half of the participants lived with Type








Type of residence Rural 146 (65.77) 51 (18.61) 197 (39.72) 113.88 <0.01
Urban 76 (34.23) 223 (81.39) 299 (60.28)
Age (years) ≤59 52 (23.42) 65 (23.72) 117 (23.59) 1.09 0.58
60 ~ 69 91 (40.99) 123 (44.89) 214 (43.15)
≥70 79 (35.59) 86 (31.39) 165 (33.27)
Sex Male 95 (42.79) 105 (38.32) 200 (40.32) 1.02 0.31
Female 127 (57.21) 169 (61.68) 296 (59.68)
Education a Middle school or higher 82 (37.79) 95 (34.67) 177 (36.05) 12.66 <0.01
Primary school 64 (29.49) 120 (43.80) 184 (37.47)
Illiterate 71 (32.72) 59 (21.53) 130 (26.48)
Income category b High 73 (33.03) 90 (33.46) 172 (35.10) 1.81 0.40
Middle 75 (33.94) 104 (38.66) 156 (31.84)
Low 73 (33.03) 75 (27.88) 162 (33.06)
Type of health insurance c UEBMI 54 (24.43) 73 (26.64) 127 (25.66) 0.31 0.58
URRBMI 167 (75.57) 201 (73.36) 368 (74.34)
Involved in the targeted disease
reimbursement program d
Yes 68 (31.05) 85 (31.02) 153 (31.03) 0.00 0.99
No 151 (68.95) 189 (68.98) 340 (68.97)
Years living with Type 2 DM ≤5 116 (52.25) 155 (56.57) 271 (54.64) 0.92 0.34
>5 106 (47.75) 119 (43.43) 225 (45.36)
a Data was missing for five patients
b Data was missing for six patients. In DJ, high income level: >US$1900.6; middle income level: US$542.2–1900.6; low income level: <US$542.2; in YB, high income
level: >US$2580.6; middle income level: US$1548.4–2580.6; low income level: <US$1548.4
c Data was missing for one patients
d Data was missing for three patients
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2 DM less than five years. Compared to YB, more partic-
ipants lived in rural areas were illiterate in DJ.
The case management of Type 2 DM
Around two-third of participants had four or more
follow-up visits (Mean ± Standard deviation, 8 ± 5) in a
year as recommended. The proportion of having at least
one HbA1c test annually was only 8.06%. Around half of
participants had blood lipid test and diabetic screening
for nephropathy and eyes at least once a year (Table 3).
Compared to YB, the proportion of having four or more
follow-up visits was slightly higher in DJ, while the pro-
portions of having recommended tests were slightly
lower. The differences between the two study sites were
not statistically significant (Table 3).
Factors associated with non-adherence of the regional
practice guidelines
Follow-up visits
In the univariate analysis, participants who were not en-
rolled in the targeted disease reimbursement program
and lived with DM less than five years were more likely
to have less than four follow-up visits in a year (Table 4).
Similar results were found in the multivariate analysis.
After adjusting for all explanatory variables, patients
who were not enrolled in the targeted disease reimburse-
ment program were three times less likely to have four
follow-up visits in a year than their counterparts (OR
2.98, 95%CI 1.85–4.81) (Table 4). Patients lived with DM
less than five years were 1.6 times less likely to have four
follow-up visits in a year than patients lived with DM
more than five years (OR 1.60, 95%CI 1.07–2.39)
(Table 4).
Annual HbA1c test
In the univariate analysis, rural residence, patients with
no education or illiterate, patients from low income
group or having URRBMI and non-enrolled in the tar-
geted disease reimbursement program were less likely to
have annual HbA1c test (Table 5). After adjusting for all
explanatory variables, only type of health insurance was
significantly associated with having HbA1c test. Patients
covered by URRBMI were five times less likely to have
HbA1c test than patients covered by UEBMI (OR 5.40,
95% CI 2.73–10.69) (Table 5).
Annual blood lipid test
The patients who were covered by URRBMI and lived
with DM less than five years were less likely to have
blood lipid test in a year (Table 6). After adjusting for all
explanatory variables, patients with URRBMI coverage
were almost two times less likely to have blood lipid test
than those with UEBMI coverage (OR 1.85, 95%CI 1.21–
2.81); while the years of living with DM was not statisti-
cally significant in relation to have this test (Table 6).
Annual diabetic nephropathy screening
Those patients who were rural residence, illiterate, were
covered by URRBMI, were not enrolled in the targeted
disease reimbursement program and lived with DM less
than five years, were less likely to have diabetic nephrop-
athy screening (Table 7). After adjusting for all explana-
tory variables, only rural residence (OR 1.74, 95%CI
1.19–2.55) and the patients non-enrolled in the targeted
disease reimbursement program (OR 1.55, 95%CI 1.05–
2.31) were statistically significantly associated with not
having this test (Table 7).
Annual diabetic eyes screening
Likewise, the patients who were rural residence,
illiterate, were covered by URRBMI and were not en-
rolled in the targeted disease reimbursement program
were less likely to have diabetic eyes screening (Table 8).
In multivariate analysis, patients covered by URRBMI
Table 3 The case management of patients with Type 2 DM in two study sites, 2013
Total standard rate (%) Areas Standarda N Sub-standard N Standard rate (%) χ2 P
Follow-up once a quarter b 64.99 DJ County 146 71 67.28 0.92 0.34
YB District 164 96 63.08
HbA1c test once a year 8.06 DJ County 13 209 5.86 2.64 0.10
YB District 27 247 9.85
Blood lipid test once a year 54.23 DJ County 114 108 51.35 1.35 0.25
YB District 155 119 56.57
Screening for nephropathy once a year 44.56 DJ County 92 130 41.44 1.58 0.21
YB District 129 145 47.08
Screening for eyes once a year 43.55 DJ County 88 134 39.64 2.50 0.11
YB District 128 146 46.72
a According to the regional practice guideline for the case management of patients with Type 2 DM, standard management was defined as patients having at
least four follow-up visits in a year and having the recommended tests once a year
b Data was missing for 19 patients
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were less likely to have this test than those covered by
UEBMI (OR 2.07, 95%CI 1.37–3.12) (Table 8). There
were no statistically significant association between other
variables and having this test.
Discussion
In our study, more than half of the participants did not
obtain services recommended the regional practice
guideline of DM case management developed for the pa-
tients with Type 2 DM. We found one-third of the pa-
tients had less than four follow-up visits in a year.
Around half of patients neither had recommended
annual blood lipid test or screening for nephropathy and
eyes and the proportion of annual HbA1c test was the
lowest. Type of health insurance coverage was signifi-
cantly associated with accessing recommended care after
adjusting for participants’ demographic and other socio-
economic status.
In China, universal coverage of essential public health
services is one of the priorities of the Chinese health sys-
tem reform launched in 2009 [6]. The essential public
health service package had nine components in 2009,
which included health management for patients with
hypertension and diabetes [12]. One study conducted in
Table 4 Factors affecting follow-up visits in a year, 2013











Involved in the targeted disease
reimbursement program a
Yes 27 (18.37) 120 (81.63) 1.00 — 1.00 —





Years living with Type 2 DM b >5 60 (27.40) 159 (72.60) 1.00 — 1.00 —





a Data was missing for 22 patients
b Data was missing for 19 patients
c Adjusted for study sites, age, sex, education, type of residence, level of income, type of health insurance, status of enrollment in the targeted disease
reimbursement program and years of living with Type 2 DM. Data without statistically significant were not shown












Type of residence Urban 268 (89.63) 31 (10.37) 1.00 — — —
Rural 188 (95.43) 9 (4.57) 2.42
(1.12 ~ 5.19)
0.02 NA NA
Education a Middle school or higher 154 (87.01) 23 (12.99) 1.00 — — —
Primary school 175 (95.11) 9 (4.89) 2.90
(1.30 ~ 6.47)
0.01 NA NA
Illiterate 122 (93.85) 8 (6.15) 2.28
(0.98 ~ 5.27)
>0.05 NA NA
Income category b High 140 (85.89) 23 (14.11) 1.00 — — —
Middle 171 (95.53) 8 (4.47) 3.51
(1.52 ~ 8.09)
<0.01 NA NA
Low 140 (94.59) 8 (5.41) 2.88
(1.24 ~ 6.65)
0.01 NA NA
Type of health insurance c UEBMI 103 (81.10) 24 (18.90) 1.00 — — —





Involved in the targeted disease
reimbursement program d
Yes 135 (88.24) 18 (11.76) 1.00 — — —
No 318 (93.53) 22 (6.47) 1.93
(1.00 ~ 3.71)
<0.05 NA NA
a Data was missing for five patients
b Data was missing for six patients
c Data was missing for one patients
d Data was missing for three patients
e Adjusted for study sites, age, sex, education, type of residence, level of income, type of health insurance, status of enrollment in the targeted disease
reimbursement program and years of living with Type 2 DM. Data without statistically significant were not shown
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the three provinces located in the eastern, central and
western China respectively reported that 90% of people
with hypertension or diabetes had at least one follow-up
visit, while around half of them had regular follow-up
visits and only one-third of the patients had blood
glucose controlled in normal range [12], which was
consistent with our findings regarding the frequency of
follow-up visits. Our study added the evidence that some
recommended tests for Type 2 DM management were
not properly taken. The proportion of having HbA1c
was the lowest, less than 10%. According to a prospect-
ive observational study in UK, any reduction in HbA1c
was significantly associated with the reduction in risks of
diabetes related clinical complications among Type 2
DM patients [13]. However, sub-standard management
for people with Type 2 DM may jeopardize efforts to
monitoring disease progression and preventing from
complications and intensive care.
The previous studies in China and other countries
found that age, sex and socio-economic status of
patients with Type 2 DM and severity of disease were
associated with the frequency of visiting doctors and the
use of services [14–18]. In our study, the participants
living with Type 2 DM more than five years were more
likely to have regular follow-up visits. This may indicates
that they have better awareness or demands for monitor-
ing and controlling disease progression. In our study,
another common factor associated with the frequency of
visits and having various recommended tests was type of
health insurance.
Table 6 Factors affecting annual blood lipid test in a year, 2013











Type of health insurance a UEBMI 44 (34.65) 83 (65.35) 1.00 — — —





Years living with Type 2 DM >5 92 (40.89) 133 (59.11) 1.00 — — —
≤5 135 (49.82) 136 (50.18) 1.44
(1.00 ~ 2.05)
<0.05 NA NA
a Data was missing for one patients
b Adjusted for study sites, age, sex, education, type of residence, level of income, type of health insurance, status of enrollment in the targeted disease
reimbursement program and years of living with Type 2 DM. Data without statistically significant were not shown
Table 7 Factors affecting Annual screening for nephropathy in a year, 2013











Type of residence Urban 150 (50.17) 149 (49.83) 1.00 — — —





Education a Middle school or higher 88 (49.72) 89 (50.28) 1.00 — — —
Primary school 102 (55.43) 82 (44.57) 1.26
(0.83 ~ 1.90)
0.28 NA NA
Illiterate 85 (65.38) 45 (34.62) 1.91
(1.20 ~ 3.05)
0.01 NA NA
Type of health insurance b UEBMI 55 (43.31) 72 (56.69) 1.00 — — —
URRBMI 219 (59.51) 149 (40.49) 1.92
(1.28 ~ 2.89)
<0.01 NA NA
Involved in the targeted disease
reimbursement program c
Yes 71 (46.41) 82 (53.59) 1.00 — — —





Years living with Type 2 DM >5 113 (50.22) 112 (49.78) 1.00 — — —
≤5 162 (59.78) 109 (40.22) 1.47
(1.03 ~ 2.11)
0.03 NA NA
a Data was missing for five patients
b Data was missing for six patients
c Data was missing for three patients
d Adjusted for study sites, age, sex, education, type of residence, level of income, type of health insurance, status of enrollment in the targeted disease
reimbursement program and years of living with Type 2 DM. Data without statistically significant were not shown
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We found that the patients covered by UEBMI were
more likely to have a standard management with regular
visits and having recommended tests than those with
coverage of URRBMI. Likewise, other previous studies in
China found that people covered by UEBMI often used
more and more expensive services than people covered
by URRBMI and NCMS [19–21]. In general, UEBMI
had a comprehensive coverage and provided higher re-
imbursement for outpatient services than the urban and
rural residence health insurance schemes [22]. Despite a
targeted disease reimbursement program was introduced
in URRBMI to provide up to US$ 160 for outpatient
reimbursement annually that was 10 times outpatient
reimbursement for non-targeted diseases [5], only one-
third participants were enrolled in the targeted disease
reimbursement program. A possible explanation is that
the patients with Type 2 DM either were not informed
of the targeted disease reimbursement program or nor
they know how to enrol in the program. In addition,
financial difficulty was cited as a common reason for not
having DM care in our study published elsewhere [5].
Without appropriately preventive interventions in the
early stage of the disease, the disease progression may
require more and more expensive care, which will cause
heavy burden for both households with people living
with DM and health system.
This study has several limitations. The participants of
this study were identified from the register of non-
communicable chronic diseases in local primary health
centers. We failed to include patients with Type 2 DM
who were not registered. These people may be more
disadvantaged on having recommended DM manage-
ment. Regarding the frequency of follow-up visit, DM
patients with severe complications were recommended
to have a follow-up visit every month. We were not able
to identify disease status of the participants due to
unable to access to their medical records. Thus, the rec-
ommended minimum four follow-up visits in a year for
all patients with Type 2 DM were used as a standard
measure in this study. In addition, this study only in-
cluded two areas (out of total 38 district/counties) of
Chongqing and only one township and one community
in each study site were selected which yielded a relatively
small sample size. This study can be viewed as a case
study and generalizations to other areas should be made
with cautions.
Conclusion
Case management for patients with Type 2 DM was not
effectively implemented in terms of frequency of follow-
up visits and recommended tests over one-year period,
as indicated in the regional practice guideline. Our study
offers evidence that suggests actions for improving
health system performance can be taken to better man-
age DM patients in China. Firstly, community and
facility-based health education will be essential to raise
patients’ awareness of the importance of Type 2 DM
management. Furthermore, the outpatient service bene-
fit package of health insurance schemes, especially for
rural and urban unemployed residences should be in-
creased in order to encourage the use of services for
chronic diseases management. Such investment will be
Table 8 Factors affecting annual diabetic eyes screening in a year, 2013










Type of residence Urban 154 (51.51) 145 (48.49) 1.00 — — —
Rural 126 (63.96) 71 (36.04) 1.67
(1.16 ~ 2.42)
0.01 NA NA
Education a Middle school or higher 90 (50.85) 87 (49.15) 1.00 — — —
Primary school 105 (57.07) 79 (42.93) 1.29
(0.85 ~ 1.95)
0.24 NA NA
Illiterate 85 (65.38) 45 (34.62) 1.83
(1.15 ~ 2.91)
0.01 NA NA
Type of health insurance b UEBMI 55 (43.31) 72 (56.69) 1.00 — — —





Involved in the targeted disease
reimbursement program c
Yes 73 (47.71) 80 (52.29) 1.00 — — —
No 207 (60.88) 133 (39.12) 1.71
(1.16 ~ 2.51)
0.01 NA NA
a Data was missing for five patients
b Data was missing for one patients
c Data was missing for three patients
d Adjusted for study sites, age, sex, education, type of residence, level of income, type of health insurance, status of enrollment in the targeted disease
reimbursement program and years of living with Type 2 DM. Data without statistically significant were not shown
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cost effective when more and intensive DM related cares
would be avoided through effective case management.
Moreover, this financial protection strategy should be
widely disseminated and be beneficiary-friendly, given
most patients with chronic diseases were elderly. In
addition, it needs further study to understand percep-
tions of health managers and healthcare providers on
chronic cases management in order to develop relevant
strategies (e.g. pay-for-performance payment, in-services
training, field support and supervision etc.) to improve
adherence to evidence-based practices and health
outcomes.
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